Merios
Longevity

The Longevity Blood Panel: Which Tests to Actually Order (2026)

The blood tests that actually predict how you age — ApoB, Lp(a), fasting insulin, hs-CRP, omega-3 index and more. What to order, the cost, how often to test.

OCT 12, 20269 MIN READLONGEVITYMERIOS EDITORIAL
Contents
  1. Why the Standard Panel Isn't Enough
  2. Cardiovascular: Look Past LDL
  3. Metabolic: Catch It at Insulin, Not Glucose
  4. Inflammation: The Quiet Accelerant
  5. Nutrients: The Cheap, High-Yield Fixes
  6. Hormones and Thyroid: The Full Picture
  7. Kidney and Advanced Markers
  8. How Often to Test
  9. Where to Get It (and What It Costs)
  10. Turning the Panel Into a Longevity Signal
  11. Sources

Walk into a standard annual physical and you will usually get a CBC, a basic metabolic panel, and a cholesterol test. That is a reasonable disease screen. It is a poor longevity panel. It will tell you whether something is wrong today, but it misses most of the markers that predict how you will age over the next twenty years — the ones that are still quietly reversible while a standard panel calls you "normal."

Over the last few years, the list of tests that longevity-focused physicians actually order has become fairly settled, and in 2026 it is what high-performers and preventive-medicine clinics build their baseline around. This guide walks through that panel marker by marker, grouped by system, with what each one tells you, roughly what it costs, and how often to repeat it. None of this is medical advice — it is a map of what to discuss with your doctor or order yourself. If you are shopping for a panel rather than interpreting one you already have, the Function Health alternatives are compared on price per biomarker.

Why the Standard Panel Isn't Enough

The problem with the standard panel is not that it is wrong. It is that it was designed to catch disease, not to measure aging. Three examples make the gap concrete.

Your standard lipid panel reports LDL cholesterol, but the number that actually drives cardiovascular risk is ApoB — a direct count of the artery-clogging particles, which can be high even when your LDL looks fine.1 Your metabolic panel reports fasting glucose, but glucose is the last thing to break; fasting insulin rises years earlier and is almost never ordered.2 And almost no standard checkup includes Lp(a), a largely genetic particle that roughly one in five people carry at high levels and that meaningfully raises heart-attack risk — despite it being a once-in-a-lifetime test.3

A longevity panel exists to close exactly these gaps: to see the drivers of aging while they are still early and movable.

Cardiovascular: Look Past LDL

Heart disease is the leading cause of death, so this is where the panel earns its keep.4 Order ApoB as your primary cardiovascular number — it captures your true particle burden better than LDL, and it is the marker to track as you make changes.1 Add Lp(a) once: if it is high, it changes how aggressively you and your doctor manage everything else; if it is low, you rarely need it again.3 Keep a standard lipid panel for context, but treat ApoB as the headline. If you want the full reasoning, see why ApoB is your real heart-risk number and why Lp(a) is the genetic risk factor you cannot ignore.

Metabolic: Catch It at Insulin, Not Glucose

Metabolic dysfunction is upstream of an enormous share of aging and chronic disease, and it is the most reversible thing on this list if you catch it early. The panel: fasting insulin, HbA1c, and fasting glucose. From fasting insulin and glucose you can calculate HOMA-IR, a simple insulin-resistance score that flags trouble years before glucose drifts up.52 Most doctors run glucose and HbA1c but skip insulin — which is like checking the smoke alarm but not the smoke. The details are in why fasting insulin is the test your doctor isn't running and the HOMA-IR score most doctors never calculate.

Inflammation: The Quiet Accelerant

Chronic, low-grade inflammation — "inflammaging" — is a through-line of the diseases that shorten life, and you can measure it cheaply.6 The core marker is hs-CRP (high-sensitivity C-reactive protein); you want it low, not merely "normal."7 Add homocysteine, an amino acid tied to cardiovascular and cognitive risk that is easily lowered with B vitamins when high, and consider GGT and uric acid, two underrated markers linked to metabolic risk and mortality beyond their textbook uses.891011 Start with understanding your hs-CRP and why high homocysteine is a missed heart risk.

Nutrients: The Cheap, High-Yield Fixes

These are the markers where a deficiency is common, silent, and easy to correct — the best return on the panel.12 Measure vitamin D, vitamin B12, ferritin (iron stores, which run low far more often than a standard CBC reveals), magnesium, and the omega-3 index.13 The omega-3 index is a standout: it measures the omega-3 content of your red blood cells, lower levels are linked to higher cardiovascular risk, and it responds directly to what you eat.1415 See the omega-3 index test and why most doctors won't fix a vitamin D deficiency.

Hormones and Thyroid: The Full Picture

Hormones govern energy, body composition, mood, and how well you hold muscle as you age, yet they are rarely tested properly. A full thyroid panel — TSH plus free T4 (and free T3) — gives the fuller picture, though guidelines still rate TSH as the single best screening test for most people.16 Test testosterone as both total and free (relevant for women as well as men), ideally with SHBG to interpret it correctly.17 For men tracking this over time, testosterone by age gives the context; for anyone whose thyroid feels off despite a "normal" TSH, the case for the full thyroid panel explains why.

Kidney and Advanced Markers

Round out the baseline with cystatin C, a kidney-function marker that, combined with creatinine, is more accurate than creatinine alone and is more strongly linked to mortality risk — see why cystatin C beats creatinine.1819 Two advanced, optional additions round out a serious panel: IGF-1, a growth factor with a genuine longevity trade-off (useful for muscle, but very high levels carry risk — covered in what IGF-1 levels mean), and a CAC scan (coronary artery calcium), which is imaging rather than blood but is one of the single best predictors of heart risk — see what your CAC score really means.2021

How Often to Test

You do not need to run all of this constantly. Establish a full baseline once, then be selective. The markers you are actively working on — ApoB, HbA1c, hs-CRP, fasting insulin — are worth retesting every three to six months, because that is how long they take to respond to real change.22 Everything else can go on a once- or twice-a-year cadence. Genetic or one-time markers like Lp(a) rarely need repeating.3 Testing monthly mostly captures biological noise, not progress. The fuller logic is in how often you should actually get blood work.

Where to Get It (and What It Costs)

You have two broad routes. You can ask your doctor to add these markers to your next requisition, which may be covered by insurance — though some, like Lp(a) or the omega-3 index, are often not, and you may have to advocate for them. Or you can order the panel yourself directly through a consumer lab, which is faster and fully transparent on price: a solid longevity panel typically runs $150–350 out of pocket, and comprehensive membership services that bundle 100+ markers run roughly $400–500 a year. If you want to go the self-order route, how to get blood work without a doctor walks through the options and the state-by-state rules. For what the best-known option actually costs all-in, see what Function Health costs in 2026.

Turning the Panel Into a Longevity Signal

Ordering the panel is the easy part. The value comes from what you do next: comparing each marker to optimal ranges rather than the wide "normal" bands, tracking the trend over time, and connecting the numbers to what you actually do. That is the whole idea behind the biomarkers that predict longevity — and the payoff is seeing your own feedback loop, whether the foods you eat for longevity pull your ApoB and CRP down, or whether the levers that lower your biological age show up in your metabolic markers a few months later.

The standard annual panel tells you if you are sick. The longevity panel tells you how fast you are aging — early enough to change it. Order the fuller set once, get your baseline, and then let the trend do the talking. Merios reads your uploaded panel, extracts every one of these markers, and tracks each against both standard and optimal ranges over time — so a page of numbers becomes a picture of how you are actually aging, and whether the work you are putting in is moving it.

Sources

22 references · checked October 12, 2026

  1. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol, 2019.PMID 31642874DOI
  2. Tabák AG, Jokela M, Akbaraly TN, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet, 2009.PMID 19515410DOI
  3. Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J, 2022.PMID 36036785DOI
  4. FastStats - Leading Causes of Death. CDC National Center for Health Statistics, 2026.
  5. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985.PMID 3899825DOI
  6. Franceschi C, Garagnani P, Parini P, et al. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol, 2018.PMID 30046148DOI
  7. Ridker PM. A Test in Context: High-Sensitivity C-Reactive Protein. J Am Coll Cardiol, 2016.PMID 26868696DOI
  8. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA, 2002.PMID 12387654DOI
  9. Smith AD, Refsum H, Bottiglieri T, et al. Homocysteine and Dementia: An International Consensus Statement. J Alzheimers Dis, 2018.PMID 29480200DOI
  10. Kunutsor SK, Apekey TA, Seddoh D, et al. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol, 2014.PMID 24585856DOI
  11. Yuan H, Yu C, Li X, et al. Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. J Clin Endocrinol Metab, 2015.PMID 26308292DOI
  12. Herrick KA, Storandt RJ, Afful J, et al. Vitamin D status in the United States, 2011-2014. Am J Clin Nutr, 2019.PMID 31076739DOI
  13. Tawfik YMK, Billingsley H, Bhatt AS, et al. Absolute and Functional Iron Deficiency in the US, 2017-2020. JAMA Netw Open, 2024.PMID 39316402DOI
  14. Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev Med, 2004.PMID 15208005DOI
  15. Flock MR, Skulas-Ray AC, Harris WS, et al. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J Am Heart Assoc, 2013.PMID 24252845DOI
  16. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid, 2012.PMID 22954017DOI
  17. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2018.PMID 29562364DOI
  18. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med, 2012.PMID 22762315DOI
  19. Shlipak MG, Matsushita K, Ärnlöv J, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med, 2013.PMID 24004120DOI
  20. Burgers AM, Biermasz NR, Schoones JW, et al. Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J Clin Endocrinol Metab, 2011.PMID 21795450DOI
  21. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med, 2008.PMID 18367736DOI
  22. A1C Test for Diabetes and Prediabetes. Centers for Disease Control and Prevention, 2024.

Frequently asked questions

  • What blood tests should I get for longevity?
    A longevity-focused panel goes well beyond the standard annual physical. The core tests are: ApoB and Lp(a) for cardiovascular risk (not just LDL); fasting insulin, HbA1c, and fasting glucose for metabolic health; hs-CRP and homocysteine for inflammation; omega-3 index, vitamin D, vitamin B12, ferritin, and magnesium for nutrients; a full thyroid panel and sex hormones; and cystatin C for kidney function. Advanced options include IGF-1 and a CAC (coronary calcium) scan, which is imaging rather than blood. The point is to catch the drivers of aging years before they show up on a basic panel.
  • What is a longevity blood panel?
    A longevity blood panel is a broader, more forward-looking set of markers than the standard CBC and metabolic panel your doctor runs at a checkup. It adds the markers most tied to long-term cardiovascular, metabolic, and inflammatory risk — like ApoB, Lp(a), fasting insulin, and hs-CRP — that predict problems early, while they are still reversible. It is designed to measure how fast you are aging on the inside, not just to screen for current disease.
  • How much does a longevity blood panel cost?
    It varies widely by how you order it. Through direct-to-consumer labs, a solid longevity panel typically runs $150–350 out of pocket, depending on how many advanced markers you include. Comprehensive membership services that bundle 100+ markers cost roughly $400–500 per year. Ordering the same markers à la carte through your own doctor and insurance can be cheaper or more expensive depending on coverage. Lp(a) usually only needs to be measured once in your life, which keeps repeat panels cheaper.
  • How often should I get a longevity panel?
    For most healthy adults, once or twice a year is the sweet spot. Establish a full baseline, then retest the markers you are actively working on — like ApoB, HbA1c, or hs-CRP — every three to six months to see whether your changes are working, since those respond on that timescale. Genetic or one-time markers like Lp(a) rarely need repeating. Testing far more often rarely adds signal and mostly captures normal biological noise.
Keep reading

More from the Journal

Longevity

Best Foods for Longevity: What to Actually Eat to Live Longer

The foods most linked to a longer life — legumes, whole grains, nuts, olive oil, fish — how much to eat, and the blood markers that show it's working.

JUL 21, 20269 MIN READ
Longevity

Best Longevity Apps 2026: Which Age Score Can You Trust?

The best longevity apps in 2026 — Whoop, Oura, Apple Health Age, NOVOS, Elysium, Function Health — compared on price and on whether the number holds up.

SEP 17, 202612 MIN READ
Longevity

Muscle and Longevity: Why Strength Predicts How Long You Live

Muscle mass and strength are among the best predictors of lifespan. Why muscle protects you as you age, how to build and keep it, and the markers that track it.

JUL 21, 20268 MIN READ
Newsletter

Like this? Get the next one in your inbox.

Merios is live on the US App Store — plus a weekly briefing with new biomarker deep-dives and plain-English study breakdowns.

Get the app